242 related articles for article (PubMed ID: 9533155)
21. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy.
Zacharakis E; Ahmed HU; Ishaq A; Scott R; Illing R; Freeman A; Allen C; Emberton M
BJU Int; 2008 Sep; 102(7):786-92. PubMed ID: 18564135
[TBL] [Abstract][Full Text] [Related]
22. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
[TBL] [Abstract][Full Text] [Related]
23. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.
Gelet A; Chapelon JY; Bouvier R; Rouvière O; Lyonnet D; Dubernard JM
Eur Urol; 2001 Aug; 40(2):124-9. PubMed ID: 11528187
[TBL] [Abstract][Full Text] [Related]
24. Salvage High-Intensity Focused Ultrasound for Local Recurrence in the Prostatic Bed after Prostatectomy and Adjuvant or Salvage Radiotherapy: Preliminary Results.
Khedime S; Gelet A; Rouvière O; Lafon C; Badet L; Crouzet S; Hostiou T
J Urol; 2021 Aug; 206(2):325-337. PubMed ID: 33835863
[TBL] [Abstract][Full Text] [Related]
25. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
[TBL] [Abstract][Full Text] [Related]
26. Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation.
Stone NN; Stock RG
Tech Urol; 1995; 1(2):72-80. PubMed ID: 9118374
[TBL] [Abstract][Full Text] [Related]
27. High-intensive focused ultrasound in localized prostate cancer.
Chaussy CG; Thüroff S
J Endourol; 2000 Apr; 14(3):293-9. PubMed ID: 10795622
[TBL] [Abstract][Full Text] [Related]
28. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
29. High-intensity focused ultrasound in prostate cancer: results after 3 years.
Chaussy C; Thüroff S
Mol Urol; 2000; 4(3):179-82. PubMed ID: 11062372
[TBL] [Abstract][Full Text] [Related]
30. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
Aus G
Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
[TBL] [Abstract][Full Text] [Related]
32. [Prostate cancer: transrectal high-intensity focused ultrasound for the treatment of local recurrence after radical prostatectomy or radiotherapy].
Tasso M; Varvello F; Ferrando U
Urologia; 2009; 76(2):73-6. PubMed ID: 21086300
[TBL] [Abstract][Full Text] [Related]
33. Outcomes after recto-anastomosis fistula repair in patients who underwent radical prostatectomy for prostate cancer.
Pfalzgraf D; Isbarn H; Reiss P; Meyer-Moldenhauer WH; Fisch M; Dahlem R
BJU Int; 2014 Apr; 113(4):568-73. PubMed ID: 24053507
[TBL] [Abstract][Full Text] [Related]
34. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
[TBL] [Abstract][Full Text] [Related]
35. Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma.
Moreira SG; Seigne JD; Ordorica RC; Marcet J; Pow-Sang JM; Lockhart JL
BJU Int; 2004 Jan; 93(1):31-5. PubMed ID: 14678363
[TBL] [Abstract][Full Text] [Related]
36. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
37. [The morbidity of radical prostatectomy using a retropubic approach: a series of 150 cases].
Bretheau D; Bochereau G; Veillon B; Brisset JM; Vallancien G
Prog Urol; 1994; 4(4):523-31. PubMed ID: 7920728
[TBL] [Abstract][Full Text] [Related]
38. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
[TBL] [Abstract][Full Text] [Related]
39. Early outcomes of active surveillance for localized prostate cancer.
Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
Wiegel T; Bartkowiak D; Bottke D; Bronner C; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Stöckle M; Rübe C; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hofmann R; Engenhart-Cabillic R; Hinke A; Hinkelbein W; Miller K
Eur Urol; 2014 Aug; 66(2):243-50. PubMed ID: 24680359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
